Clinical Trials on CAR-T Cell Immunotherapy
Total 1965 results
-
iCell Gene TherapeuticsPeking University Shenzhen Hospital; iCAR Bio Therapeutics Ltd.RecruitingT-cell Acute Lymphoblastic Leukemia | T-cell Non-Hodgkin Lymphoma | T-cell Acute Lymphoblastic LymphomaChina
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingPeripheral T-cell Lymphoma
-
Sun Yat-sen UniversityRecruitingPeripheral T-cell LymphomaChina
-
Ruijin HospitalRecruitingPeripheral T-cell LymphomaChina
-
Huda SalmaniCell Gene TherapeuticsRecruiting
-
Spectrum Pharmaceuticals, IncOnxeoCompletedPeripheral T-cell LymphomaUnited States, Belgium, United Kingdom, Germany, Spain, Poland, Israel, Netherlands, Canada, Croatia, Denmark, France, Hungary, Italy, Russian Federation, Slovakia, South Africa
-
National Cancer Centre, SingaporeCompletedPeripheral T-cell LymphomaSingapore
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownPeripheral T-cell LymphomaChina
-
M.D. Anderson Cancer CenterOrtho Biotech, Inc.Completed
-
Mingzhi ZhangUnknownPeripheral T-cell LymphomaChina
-
CelgeneCompletedPeripheral T-cell LymphomaUnited States, Spain, Germany, France, Czechia, Australia, Sweden, United Kingdom, Ukraine, Poland
-
CelgeneCompleted
-
Sun Yat-sen UniversityUnknownPeripheral T-cell LymphomaChina
-
Northwestern UniversityCompleted
-
University of BolognaTerminatedPeripheral T-cell LymphomaItaly
-
King Chulalongkorn Memorial HospitalBayerCompleted
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Recurrent Grade 3a Follicular Lymphoma | Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Recurrent Mycosis Fungoides | Recurrent Primary Cutaneous... and other conditionsUnited States, Canada
-
Sorrento Therapeutics, Inc.RecruitingMycosis FungoidesUnited States
-
Washington University School of MedicineNational Cancer Institute (NCI); Invivoscribe, Inc.; T-Cell Leukemia Lymphoma...Active, not recruiting
-
Rochester General HospitalBausch Health Americas, Inc.; Rochester Skin Lymphoma Medical Group, PLLCWithdrawn
-
Fudan UniversityRecruitingNatural Killer/T-Cell Lymphoma, Nasal and Nasal-TypeChina
-
Fudan UniversityRecruitingPeripheral T-cell LymphomaChina
-
Rong TaoRecruitingNatural Killer/T-Cell Lymphoma, Nasal and Nasal-TypeChina
-
Kyowa Kirin, Inc.RecruitingCutaneous T Cell Lymphoma | ATLL | Leukemia/LymphomaUnited States
-
Xinhua Hospital, Shanghai Jiao Tong University...CompletedNatural Killer/T-Cell Lymphoma, Nasal and Nasal-TypeChina
-
German CLL Study GroupGenzyme, a Sanofi Company; University of CologneCompletedT-cell-prolymphocytic LeukemiaGermany
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; National Cancer Institute (NCI); NYU Langone Health and other collaboratorsCompleted
-
Mingzhi ZhangUnknownNatural Killer/T-Cell Lymphoma, Nasal and Nasal-TypeChina
-
Sun Yat-sen UniversityFudan University; Cancer Institute and Hospital, Chinese Academy of Medical... and other collaboratorsUnknownHigh Risk | T-cell Lymphoma Adults | Previously UntreatedChina
-
BioCryst PharmaceuticalsCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLymphomaUnited States
-
Peking Union Medical College HospitalUnknownDiffuse Large B Cell Lymphoma | Peripheral T-Cell Lymphoma | Lymphoma,Non-Hodgkin
-
Cancer Institute and Hospital, Chinese Academy...Peking University Cancer Hospital & Institute; The Affiliated Hospital Of Guizhou... and other collaboratorsRecruitingHigh-Risk Cancer | Early-stage | Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-TypeChina
-
AstraZenecaCompletedRelapsed/Refractory Peripheral T-cell Lymphoma | Relapsed/Refractory Classical Hodgkins LymphomaItaly, Sweden, United States, Taiwan, Korea, Republic of, United Kingdom, Australia, France, Singapore
-
GenmabCompletedCutaneous T-Cell LymphomaUnited Kingdom, Germany, United States, Sweden
-
Kura Oncology, Inc.AvailableHRAS Mutations or Peripheral T Cell Lymphoma (PTCL)
-
Xinhua Hospital, Shanghai Jiao Tong University...CompletedNatural Killer/T-Cell Lymphoma, Nasal and Nasal-TypeChina
-
Jonsson Comprehensive Cancer CenterMillennium Pharmaceuticals, Inc.CompletedLymphomaUnited States
-
Peking UniversityPeking University International Hospital; Jiangxi Provincial Cancer Hospital; Shandong Tumor HospitalUnknownExperimental TumorChina
-
AHS Cancer Control AlbertaAlberta Cancer Foundation; Celgene CorporationCompleted
-
MillennixUnknownLymphomaUnited States
-
BioCryst PharmaceuticalsCompleted
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)Completed
-
Canadian Cancer Trials GroupCelgeneCompletedDiffuse Large B-Cell Lymphoma | Peripheral T-Cell LymphomaCanada
-
Sorrento Therapeutics, Inc.WithdrawnDiffuse Large B Cell Lymphoma | Biliary Tract Cancer | Peripheral T Cell Lymphoma | Extranodal NK T Cell Lymphoma, Nasal
-
Seagen Inc.Millennium Pharmaceuticals, Inc.CompletedNon-Hodgkin Lymphoma | T-Cell Lymphoma | Anaplastic Large-Cell LymphomaUnited States, Korea, Republic of, Spain, United Kingdom, Taiwan, Czechia, Hungary, France, Israel, Germany, Italy, Denmark, Australia, Poland, Romania, Canada
-
Sun Yat-sen UniversityRecruitingExtranodal Natural Killer T Cell LymphomaChina
-
Ono Pharmaceutical Co. LtdRecruitingRelapsed or Refractory T Cell LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterUniversity of NebraskaCompletedT-cell Lymphomas | Relapsed or RefractoryUnited States